Carregant...
Developments and opportunities in continuous biopharmaceutical manufacturing
Today’s biologics manufacturing practices incur high costs to the drug makers, which can contribute to high prices for patients. Timely investment in the development and implementation of continuous biomanufacturing can increase the production of consistent-quality drugs at a lower cost and a faster...
Guardat en:
| Publicat a: | MAbs |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8043180/ https://ncbi.nlm.nih.gov/pubmed/33843449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2021.1903664 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|